Editor(s):
(1) Dr. David E. Martin, Martin Pharma Consulting, USA And DFH Pharma Inc, Maryland.
(2) Dr. Gonzalo Emiliano Aranda Abreu, Brain Research Center, Veracruzana University, Mexico.
(3) Dr. Paola Angelini, University of Perugia, Perugia, Italy.
Reviewers:
(1) Lamia Fouad Fathi, Ain Shams University, Egypt.
(2) Shahla Jamal Shakkor, Kirkuk University, Iraq.
(3) Warkaa M.Al-Wattar, Mustansiriyah University, Iraq.
(4) Ayub Irmadani Anwar, Hasanuddin University, Indonesia.
(5) Rosaura Caron Estrada, Universidad Mayor de San Andres, Bolivia.
Additional Reviewers:
Open Peer Review Policy: Click Here
Specific Comment:
Average Peer review marks at initial stage: 8.4/10
Average Peer review marks at publication stage: 9/10
Peer Review History:
Stage 1 | Original Manuscript | File 1 | NA
Stage 2 | Peer review report_1 (Lamia Fouad Fathi, Egypt) | File 1 | NA
Stage 2 | Peer review report_2 (Shahla Jamal Shakkor, Iraq) | File 1 | NA
Stage 2 | Peer review report_3 (Warkaa M.Al-Wattar, Iraq) | File 1 | NA
Stage 2 | Peer review report_4 (Ayub Irmadani Anwar, Indonesia) | File 1 | NA
Stage 2 | Peer review report_5 (Rosaura Caron Estrada, Bolivia) | File 1 | NA
Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2
Stage 3 | Comment_Editor_1_v1 | File 1 | NA
Stage 3 | Comment_Editor_2_v1 | File 1 | NA
Stage 3 | Comment_Editor_3_v1 | File 1 | NA